{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:35:10Z","timestamp":1765280110467,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["0019\/SDU\/2018\/18"],"award-info":[{"award-number":["0019\/SDU\/2018\/18"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008476","name":"University of California Irvine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008476","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12957-019-1633-5","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T18:10:47Z","timestamp":1559585447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC)"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5703-5787","authenticated-orcid":false,"given":"Justyna","family":"Schubert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veria","family":"Khosrawipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haris","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Arafkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram Trudo","family":"Knoefel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Pigazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Khosrawipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"issue":"10","key":"1633_CR1","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2217\/fon.10.100","volume":"6","author":"Z Lu","year":"2010","unstructured":"Lu Z, Wang J, Wientjes MG, Au JL. Intraperitoneal therapy for peritoneal cancer. Future Oncol. 2010;6(10):1625\u201341.","journal-title":"Future Oncol."},{"issue":"1-3","key":"1633_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0168-3659(01)00488-6","volume":"78","author":"JL Au","year":"2002","unstructured":"Au JL, Jang SH, Wientjes MG. Clinical aspects of drug delivery to tumors. J Controlled Release. 2002;78(1-3):81\u201395.","journal-title":"J Controlled Release."},{"key":"1633_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/scientificamerican0794-58","volume":"271","author":"RK Jain","year":"1994","unstructured":"Jain RK. Barriers to drug delivery in solid tumors. Sci Am. 1994;271:58\u201365.","journal-title":"Sci Am."},{"issue":"7","key":"1633_CR4","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","volume":"26","author":"W Sola\u00df","year":"2012","unstructured":"Sola\u00df W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012;26(7):1849\u201355.","journal-title":"Surg Endosc."},{"issue":"10","key":"1633_CR5","first-page":"12","volume":"19","author":"T Khosrawipour","year":"2017","unstructured":"Khosrawipour T, Khosrawipour V, Giger-Pabst U. Pressurized intra peritoneal aerosol chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma. PLoS One. 2017;19(10):12.","journal-title":"PLoS One."},{"issue":"23","key":"1633_CR6","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.7150\/jca.26860","volume":"20;9","author":"A Mikolajczyk","year":"2018","unstructured":"Mikolajczyk A, Khosrawipour V, Schubert J, Grzesiak J, Chaudhry H, Pigazzi A, Khosrawipour T. Effect of liposomal doxorubicin in pressurized intra-peritoneal aerosol chemotherapy (PIPAC). J Cancer. 2018;20;9(23):4301\u20135.","journal-title":"J Cancer"},{"issue":"8","key":"1633_CR7","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.21873\/anticanres.12769","volume":"38","author":"A Mikolajczyk","year":"2018","unstructured":"Mikolajczyk A, Khosrawipour V, Schubert J, Chaudhry H, Pigazzi A, Khosrawipour T. Particle stability during pressurized intra-peritoneal aerosol chemotherapy (PIPAC). Anticancer Res. 2018;38(8):4645\u20139.","journal-title":"Anticancer Res."},{"issue":"26","key":"1633_CR8","doi-asserted-by":"crossref","first-page":"22776","DOI":"10.18632\/oncotarget.4309","volume":"8;6","author":"M Nowacki","year":"2015","unstructured":"Nowacki M, Wisniewski M, Werengowska-Ciecwierz K, Roszek K, Czarnecka J, \u0141akomska I, Kloskowski T, Tyloch D, Debski R, Pietkun K, Pokrywczynska M, Grzanka D, Czajkowski R, Drewa G, Jundzi\u0142\u0142 A, Agyin JK, Habib SL, Terzyk AP, Drewa T. Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis. Oncotarget. 2015;8;6(26):22776\u201398.","journal-title":"Oncotarget."},{"issue":"9","key":"1633_CR9","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.21873\/anticanres.11008","volume":"36","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Khosrawipour T, Falkenstein TA, Diaz-Carballo D, F\u00f6rster E, Osma A, Adamietz IA, Zieren J, Fakhrian K. Evaluating the effect of Micropump\u00a9 position, internal pressure and doxorubicin dosage on efficacy of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model. Anticancer Res. 2016;36(9):4595\u2013600.","journal-title":"Anticancer Res"},{"issue":"7","key":"1633_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1023\/A:1011988923523","volume":"18","author":"C Braumann","year":"2000","unstructured":"Braumann C, Ordemann J, Wildbrett P, Jacobi CA. Influence of intraperitoneal and systemic application of taurolidine and taurolidine\/heparin during laparoscopy on intraperitoneal and subcutaneous tumor growth in rats. Clin Exp Metastasis. 2000;18(7):547\u201352.","journal-title":"Clin Exp Metastasis."},{"issue":"4 Suppl 1","key":"1633_CR11","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1007\/PL00014641","volume":"382","author":"CA Jacobi","year":"1997","unstructured":"Jacobi CA, Sabat R, Ordemann J, Wenger F, Volk HD, M\u00fcller JM. Peritoneal instillation of taurolidine and heparin for preventing intraperitoneal tumor growth and trocar metastases in laparoscopic operations in the rat model. Langenbecks Arch Chir. 1997;382(4 Suppl 1):S31\u20136 German.","journal-title":"Langenbecks Arch Chir"},{"issue":"7","key":"1633_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00384-006-0239-x","volume":"22","author":"H Frieling","year":"2007","unstructured":"Frieling H, Lauer KS, Gr\u00fcndling M, Usichenko T, Meissner K, Kanellopoulou T, Lehmann C, Wendt M, Pavlovic D. Peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemia. Int J Colorectal Dis. 2007;22(7):807\u201317.","journal-title":"Int J Colorectal Dis."},{"issue":"6","key":"1633_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00383-005-1428-3","volume":"21","author":"A Schneider","year":"2005","unstructured":"Schneider A, Sack U, Rothe K, Bennek J. Peritoneal taurolidine lavage in children with localised peritonitis due to appendicitis. Pediatr Surg Int. 2005;21(6):445\u20138.","journal-title":"Pediatr Surg Int."},{"issue":"5","key":"1633_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s00595-005-3155-8","volume":"36","author":"A Akku\u015f","year":"2006","unstructured":"Akku\u015f A, G\u00fclmen M, Cevik A, Bildik N, Sad O, Ozt\u00fcrk E, Bari\u015fik NO. Effect of peritoneal lavage with taurolidine on primary colonic anastomosis in a rat model of secondary peritonitis. Surg Today. 2006;36(5):436\u201340.","journal-title":"Surg Today."},{"issue":"4","key":"1633_CR15","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","volume":"31","author":"D G\u00f6hler","year":"2017","unstructured":"G\u00f6hler D, Khosrawipour V, Khosrawipour T, Diaz-Carballo D, Falkenstein TA, Zieren J, Stintz M, Giger-Pabst U. Technical description of the microinjection pump (MIP\u00ae) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Endosc. 2017;31(4):1778\u201384.","journal-title":"Surg Endosc"},{"key":"1633_CR16","doi-asserted-by":"crossref","unstructured":"Khosrawipour T, Wu D, Bellendorf A, Mohanaraja KE, Diaz-Carballo D, Khosrawipour V. Feasibility of single tumor spot treatment in peritoneal carcinomatosis via close range doxorubicin impaction in pressurized intra-peritoneal aerosol chemotherapy (PIPAC). J Clin Exp Oncol. 2017;6(3). \n                    https:\/\/www.scitechnol.com\/peer-review\/feasibility-of-single-tumorspot-treatment-in-peritoneal-carcinomatosis-via-close-range-doxorubicin-impaction-in-pressurized-intrap-sG1B.php?article_id=6082\n                    \n                  .","DOI":"10.4172\/2324-9110.1000187"},{"issue":"6","key":"1633_CR17","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.21873\/anticanres.12613","volume":"38","author":"V Khosrawipour","year":"2018","unstructured":"Khosrawipour V, Mikolajczyk A, Schubert J, Khosrawipour T. Pressurized intra-peritoneal aerosol chemotherapy (PIPAC) via endoscopical microcatheter system. Anticancer Res. 2018;38(6):3447\u201352.","journal-title":"Anticancer Res."},{"key":"1633_CR18","unstructured":"Khosrawipour T, Schubert J, Khosrawipour V, Chaudhry H, Grzesiak J, Arafkas M, Mikolajczyk A. Particle stability and structure on the peritoneal surface in pressurized intra-peritoneal aerosol chemotherapy (PIPAC) analysed by electron microscopy: first evidence of a new physical concept for PIPAC [accepted for publication at Oncol Letters]."},{"issue":"1","key":"1633_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12957-017-1109-4","volume":"10;15","author":"V Khosrawipour","year":"2017","unstructured":"Khosrawipour V, Diaz-Carballo D, Acikelli AH, Khosrawipour T, Falkenstein TA, Wu D, Zieren J, Giger-Pabst U. Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells. World J Surg Oncol. 2017;10;15(1):43.","journal-title":"World J Surg Oncol"},{"issue":"5","key":"1633_CR20","first-page":"593","volume":"30","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Bellendorf A, Khosrawipour C, Hedayat-Pour Y, Diaz-Carballo D, F\u00f6rster E, M\u00fccke R, Kabakci B, Adamietz IA, Fakhrian K. Irradiation does not increase the penetration depth of doxorubicin in normal tissue after pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an Ex Vivo Model. In Vivo. 2016;30(5):593\u20137.","journal-title":"In Vivo."},{"issue":"8","key":"1633_CR21","doi-asserted-by":"publisher","first-page":"910","DOI":"10.7150\/jca.14714","volume":"7","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Giger-Pabst U, Khosrawipour T, Pour YH, Diaz-Carballo D, F\u00f6rster E, B\u00f6se-Ribeiro H, Adamietz IA, Zieren J, Fakhrian K. Effect of irradiation on tissue penetration depth of doxorubicin after pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in a novel ex-vivo model. J Cancer. 2016;7(8):910\u201324.","journal-title":"J Cancer."},{"issue":"4","key":"1633_CR22","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1245\/s10434-015-4954-9","volume":"23","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Khosrawipour T, Diaz-Carballo D, F\u00f6rster E, Zieren J, Giger-Pabst U. Exploring the spatial drug distribution pattern of pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol. 2016;23(4):1220\u20134.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"1633_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0002-9610(97)00099-8","volume":"174","author":"CA Jacobi","year":"1997","unstructured":"Jacobi CA, Ordemann J, B\u00f6hm B, Zieren HU, Sabat R, M\u00fcller JM. Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model. Am J Surg. 1997;174(3):359\u201363.","journal-title":"Am J Surg."},{"issue":"4","key":"1633_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jamcollsurg.2017.12.027","volume":"226","author":"EA Levine","year":"2018","unstructured":"Levine EA, Votanopoulos KI, Shen P, Russell G, Fenstermaker J, Mansfield P, Bartlett D, Stewart JH. A multicenter randomized trial to evaluate hematologic toxicities after hyperthermic intraperitoneal chemotherapy with oxaliplatin or mitomycin in patients with appendiceal tumors. J Am Coll Surg. 2018;226(4):434\u201343.","journal-title":"J Am Coll Surg"},{"key":"1633_CR25","doi-asserted-by":"crossref","unstructured":"van Eden WJ, NFM K, Woensdregt K, ADR H, Boot H, AGJ A. Safety of intraperitoneal mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC. Eur J Surg Oncol. 201;8; 44(2):220\u20137.","DOI":"10.1016\/j.ejso.2017.10.216"},{"issue":"1","key":"1633_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejso.2016.09.015","volume":"43","author":"V Leung","year":"2017","unstructured":"Leung V, Huo YR, Liauw W, Morris DL. Oxaliplatin versus mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis. Eur J Surg Oncol. 2017;43(1):144\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"1633_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ctrv.2004.12.006","volume":"31","author":"D KWEEKEL","year":"2005","unstructured":"Kweekel DM, Gelderblom H, Guchelaar HJ. Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy. Cancer Treat Rev. 2005;(2):90\u2013105.","journal-title":"Cancer Treatment Reviews"},{"issue":"4","key":"1633_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2217\/pme-2017-0082","volume":"1;15","author":"M Basso","year":"2018","unstructured":"Basso M, Dadduzio V, Rossi S, D\u2019Argento E, Strippoli A, Di Salvatore M, Orlandi A, Zurlo V, Di Noia V, Barone C. The interference between oxaliplatin & anti-EGFR therapies: a different hypothesis to explain the 'unexplainable'. Per Med. 2018;1;15(4):319\u201327.","journal-title":"Per Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-019-1633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-019-1633-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-019-1633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:01:15Z","timestamp":1591056075000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-019-1633-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1633"],"URL":"https:\/\/doi.org\/10.1186\/s12957-019-1633-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"type":"electronic","value":"1477-7819"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No patient or animal tissue or data was needed for this in vitro cell study. The used human cancer cells lines were commercially acquired. Therefore, no approval of the ethics committee was required or applicable for the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This is not applicable since our manuscript does not include any individual person\u2019s data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}